Literature DB >> 20226020

Outcome of coronary plaque burden: a 10-year follow-up of aggressive medical management.

Victor K Goh1, Chu-Pak Lau, Stefan Mohlenkamp, John A Rumberger, Stephan Achenbach, Matthew J Budoff.   

Abstract

BACKGROUND: The effect of aggressive medical therapy on quantitative coronary plaque burden is not generally known, especially in ethnic Chinese. AIMS: We reasoned that Cardiac CT could conveniently quantify early coronary atherosclerosis in our patient population, and hypothesized that serial observation could differentiate the efficacy of aggressive medical therapy regarding progression and regression of the atherosclerotic process, as well as evaluating the additional impact of life-style modification and the relative effects of the application of statin therapy.
METHODS: We employed a standardized Cardiac CT protocol to serially scan 113 westernized Hong Kong Chinese individuals (64 men and 49 women) with Chest Pain and positive coronary risk factors. In all cases included for this serial investigation, subsequent evaluation showed no significantly-obstructive coronary disease by functional studies and angiography. After stringent risk factor modification, including aggressive statin therapy to achieve LDL-cholesterol lowering conforming to N.C.E.P. ATP III guidelines, serial CT scans were performed 1-12 years apart for changes in coronary artery calcification (CAC), using the Agatston Score (AS) for quantification.
RESULTS: At baseline, the mean AS was 1413.6 for males (mean age 54.4 years) and 2293.3 for females (mean age 62.4 years). The average increase of AS in the entire study population was 24% per year, contrasting with 16.4% per year on strict risk factor modification plus statin therapy, as opposed to 33.2% per year for historical control patients (p < 0.001). Additionally, 20.4% of the 113 patients demonstrated decreasing calcium scores. Medical therapy also yielded a remarkably low adverse event rate during the follow-up period --- 2 deaths, 2 strokes and only 1 case requiring PCI.
CONCLUSIONS: This study revealed that aggressive medical therapy can positively influence coronary plaque aiding in serial regression of calcium scores.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20226020      PMCID: PMC2850323          DOI: 10.1186/1476-7120-8-5

Source DB:  PubMed          Journal:  Cardiovasc Ultrasound        ISSN: 1476-7120            Impact factor:   2.062


  37 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Progression of coronary artery calcification: a pilot study.

Authors:  J E Maher; L F Bielak; J A Raz; P F Sheedy; R S Schwartz; P A Peyser
Journal:  Mayo Clin Proc       Date:  1999-04       Impact factor: 7.616

Review 3.  Computed tomography--an increasing source of radiation exposure.

Authors:  David J Brenner; Eric J Hall
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

4.  Shape-based interpolation of multidimensional objects.

Authors:  S P Raya; J K Udupa
Journal:  IEEE Trans Med Imaging       Date:  1990       Impact factor: 10.048

5.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

6.  Comparison of serial quantitative evaluation of calcified coronary artery plaque by ultrafast computed tomography in persons with and without obstructive coronary artery disease.

Authors:  W R Janowitz; A S Agatston; M Viamonte
Journal:  Am J Cardiol       Date:  1991-07-01       Impact factor: 2.778

7.  Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults.

Authors:  J A Hoff; E V Chomka; A J Krainik; M Daviglus; S Rich; G T Kondos
Journal:  Am J Cardiol       Date:  2001-06-15       Impact factor: 2.778

8.  Relation of coronary calcium progression and control of lipids according to National Cholesterol Education Program guidelines.

Authors:  Nathan D Wong; Miwa Kawakubo; Laurie LaBree; Stanley P Azen; Min Xiang; Robert Detrano
Journal:  Am J Cardiol       Date:  2004-08-15       Impact factor: 2.778

9.  Serum lipid profile and its association with some cardiovascular risk factors in an urban Chinese population.

Authors:  E Lau; J Woo; C S Cockram; A Chan; C W Lam; R Swaminathan; S P Donnan
Journal:  Pathology       Date:  1993-10       Impact factor: 5.306

10.  Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers.

Authors:  Dhakshinamurthy Vijay Anand; Eric Lim; Daniel Darko; Paul Bassett; David Hopkins; David Lipkin; Roger Corder; Avijit Lahiri
Journal:  J Am Coll Cardiol       Date:  2007-11-19       Impact factor: 24.094

View more
  4 in total

Review 1.  Progression of coronary artery calcification at the crossroads: sign of progression or stabilization of coronary atherosclerosis?

Authors:  Gaston A Rodriguez-Granillo; Patricia Carrascosa; Nico Bruining
Journal:  Cardiovasc Diagn Ther       Date:  2016-06

Review 2.  Coronary CT angiography in managing atherosclerosis.

Authors:  Joachim Eckert; Marco Schmidt; Annett Magedanz; Thomas Voigtländer; Axel Schmermund
Journal:  Int J Mol Sci       Date:  2015-02-09       Impact factor: 5.923

3.  Comparison of coronary arterial lumen dimensions on angiography and plaque characteristics on optical coherence tomography images and their changes induced by statin.

Authors:  Nana Dong; Zulong Xie; Wei Wang; Jiannan Dai; Meng Sun; Zhongyue Pu; Jinwei Tian; Bo Yu
Journal:  BMC Med Imaging       Date:  2016-11-22       Impact factor: 1.930

4.  Effects of long-term statin-treatment on coronary atherosclerosis in patients with inflammatory joint diseases.

Authors:  Mona Svanteson; Silvia Rollefstad; Nils-Einar Kløw; Jonny Hisdal; Eirik Ikdahl; Joseph Sexton; Ylva Haig; Anne Grete Semb
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.